Treatment of atrial fibrillation with doxapram: TASK-1 potassium channel inhibition as a novel pharmacological strategy
October 5, 2022 9:35 pmWiedmann F […] Kraft M, Paasche A […] Schmidt C. Treatment of atrial fibrillation with doxapram: TASK-1 potassium channel inhibition as a novel pharmacological strategy. Cardiovasc Res 2022/118(7):1728-1741. doi: 10.1093/cvr/cvab177.
Categorised in:
This post was written by sfb1425
